2023
The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence
Ragnhildstveit A, Roscoe J, Bass L, Averill C, Abdallah C, Averill L. The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence. Therapeutic Advances In Psychopharmacology 2023, 13: 20451253231154125. PMID: 36895431, PMCID: PMC9989422, DOI: 10.1177/20451253231154125.Peer-Reviewed Original ResearchPosttraumatic stress disorderClinical evidenceStress disorderMethyl-d-aspartate (NMDA) receptor antagonistLow patient engagementRobust antidepressant effectsOpen-label studyOnset of actionPotential of ketamineQuality of lifeMedical comorbiditiesAntidepressant effectsChart reviewRefractory casesDisease chronicityClinical presentationRandomized trialsCase reportDevastating conditionReceptor antagonistMajor depressionPharmacological approachesPsychiatric disordersPharmacological agentsTherapeutic safety
2009
Preliminary Evidence on the Effectiveness of Psychological Treatments Delivered at a University Counseling Center
Minami T, Davies D, Tierney S, Bettmann J, McAward S, Averill L, Huebner L, Weitzman L, Benbrook A, Serlin R, Wampold B. Preliminary Evidence on the Effectiveness of Psychological Treatments Delivered at a University Counseling Center. Journal Of Counseling Psychology 2009, 56: 309-320. DOI: 10.1037/a0015398.Peer-Reviewed Original ResearchClinical trialsTreatment effect size estimatesPoor treatment outcomesPre-post outcomesUniversity counseling centerClinical symptom measuresDifferential treatment effectsAdult major depressionProblematic substance useClinical cutoff scoresPoor outcomeOutcome Questionnaire-45.2Counseling centersEfficacy benchmarksMajor depressionTreatment outcomesTreatment efficacyTreatment dataSubstance usePsychological distressPsychological treatmentSymptom measuresCutoff scoreEffect size estimatesTreatment effects